CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-08 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −10,000 | 400,303 | ||
| 2020-03-16 | DEMAREE JOHN Chief Commercial Officer | Grant or award · Nonstatutory Stock Option (right to buy) | +151,200 | 151,200 | ||
| 2020-03-13 | Greene Barry E Director | Exercise or conversion | +3,030 | $0.03 | $100 | 6,030 |
| 2020-03-13 | Greene Barry E Director | Exercise or conversion · Stock Option (right to buy) | −3,030 | 0 | ||
| 2020-03-10 | Shacham Sharon President & CSO | Exercise or conversion | +10,000 | $4.75 | $48K | 565,122 |
| 2020-03-10 | Shacham Sharon President & CSO | Sale | −7,932 | $22.11 | $175K | 557,190 |
| 2020-03-10 | Shacham Sharon President & CSO | Sale | −2,068 | $22.64 | $47K | 555,122 |
| 2020-03-10 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −10,000 | 366,061 | ||
| 2020-03-10 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +10,000 | $4.75 | $48K | 565,122 |
| 2020-03-10 | Kauffman Michael Chief Executive Officer | Sale | −7,932 | $22.11 | $175K | 557,190 |
| 2020-03-10 | Kauffman Michael Chief Executive Officer | Sale | −2,068 | $22.64 | $47K | 555,122 |
| 2020-03-10 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 366,061 | ||
| 2020-03-09 | Shacham Sharon President & CSO | Exercise or conversion | +10,000 | $4.75 | $48K | 766,489 |
| 2020-03-09 | Shacham Sharon President & CSO | Sale | −7,000 | $22.58 | $158K | 759,489 |
| 2020-03-09 | Shacham Sharon President & CSO | Sale | −3,000 | $22.38 | $67K | 756,489 |
| 2020-03-09 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −10,000 | 410,303 | ||
| 2020-03-09 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +10,000 | $4.75 | $48K | 766,489 |
| 2020-03-09 | Kauffman Michael Chief Executive Officer | Sale | −7,000 | $22.58 | $158K | 759,489 |
| 2020-03-09 | Kauffman Michael Chief Executive Officer | Sale | −3,000 | $22.38 | $67K | 756,489 |
| 2020-03-09 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 410,303 |
Page 27 of 29 · 570 trades